Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas

被引:11
|
作者
Xu, Richard Huan [1 ,2 ]
Wong, Eliza Lai Yi [1 ,2 ]
Jin, Jun [3 ]
Dou, Ying [3 ]
Dong, Dong [1 ,2 ,4 ]
机构
[1] Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Ctr Hlth Syst & Policy Res, Hong Kong, Peoples R China
[3] Tsinghua Univ, Sch Social Sci, Dept Sociol, Beijing, Peoples R China
[4] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China
来源
EUROPEAN JOURNAL OF HEALTH ECONOMICS | 2020年 / 21卷 / 09期
关键词
EORTC QLQ-C30; EQ-5D-5L; Mapping algorithm; Lymphoma; China; VARIABLE MIXTURE-MODELS; OF-LIFE INSTRUMENTS; EUROPEAN-ORGANIZATION; UTILITY VALUES; QUALITY; VALIDITY;
D O I
10.1007/s10198-020-01220-w
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objective The objective of this study was to develop algorithms to map the EORTC QLQ-C30 (QLQ-C30) onto EQ-5D-5L in a sample of patients with lymphomas. Methods An online nationwide survey of patients with lymphoma was carried out in China. Ordinary least squares (OLS), beta-based mixture, adjusted limited dependent variable mixture regression, and a Tobit regression model were used to develop the mapping algorithms. The QLQ-C30 subscales/items, their squared and interaction terms, and respondents' demographic variables were used as independent variables. The root mean square error (RMSE), mean absolute error (MAE), and R-squared (R-2) were estimated based on tenfold cross-validation to assess the predictive ability of the selected models. Results Data of 2222/4068 respondents who self-completed the online survey were elicited for analyses. The mean EQ-5D-5L index score was 0.81 (SD0.21, range - 0.81-1.0). 19.98% of respondents reported an index score at 1.0. In total, 72 models were generated based on four regression methods. According to the RMSE, MAE andR(2), the OLS model including QLQ-C30 subscales, squared terms, interaction terms, and demographic variables showed the best fit for overall and the Non-Hodgkin's lymphoma sample; for Hodgkin's lymphoma, the ALDVMM with 1-component model, including QLQ-C30 subscales, squared terms, interaction terms, and demographic variables, showed a better fit than the other models. Conclusion The mapping algorithms enable the EQ-5D-5L index scores to be predicted by QLQ-C30 subscale/item scores with good precision in patients living with lymphomas.
引用
收藏
页码:1363 / 1373
页数:11
相关论文
共 50 条
  • [31] Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after
    Miret, Carme
    Orive, Miren
    Sala, Maria
    Garcia-Gutierrez, Susana
    Sarasqueta, Cristina
    Jose Legarreta, Maria
    Redondo, Maximino
    Rivero, Amado
    Castells, Xavier
    Quintana, Jose M.
    Garin, Olatz
    Ferrer, Montse
    QUALITY OF LIFE RESEARCH, 2023, 32 (04) : 989 - 1003
  • [32] Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after
    Carme Miret
    Miren Orive
    Maria Sala
    Susana García-Gutiérrez
    Cristina Sarasqueta
    Maria Jose Legarreta
    Maximino Redondo
    Amado Rivero
    Xavier Castells
    José M. Quintana
    Olatz Garin
    Montse Ferrer
    Quality of Life Research, 2023, 32 : 989 - 1003
  • [33] Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D
    Lamu, Admassu N.
    Olsen, Jan Abel
    QUALITY OF LIFE RESEARCH, 2018, 27 (11) : 2823 - 2839
  • [34] Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer
    Marriott, Emily-Ruth
    van Hazel, Guy
    Gibbs, Peter
    Hatswell, Anthony J.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (02) : 193 - 199
  • [35] Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients
    Kim, Eun-ju
    Ko, Su-Kyoung
    Kang, Hye-Young
    QUALITY OF LIFE RESEARCH, 2012, 21 (07) : 1193 - 1203
  • [36] Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients
    Eun-ju Kim
    Su-Kyoung Ko
    Hye-Young Kang
    Quality of Life Research, 2012, 21 : 1193 - 1203
  • [37] MAPPING THE CANCER-SPECIFIC EORTC QLQ-C30 AND EORTC QLQ-BR23 TO THE GENERIC EQ-5D IN METASTATIC BREAST CANCER PATIENTS
    Kang, H.
    Ko, S. K.
    Kim, E. J.
    VALUE IN HEALTH, 2011, 14 (07) : A458 - A458
  • [38] Correction: Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after
    Carme Miret
    Miren Orive
    Maria Sala
    Susana García-Gutiérrez
    Cristina Sarasqueta
    Maria Jose Legarreta
    Maximino Redondo
    Amado Rivero
    Xavier Castells
    José M. Quintana
    Olatz Garin
    Montse Ferrer
    Quality of Life Research, 2024, 33 : 1433 - 1435
  • [39] Mapping QLQ-C30 Onto EQ-5D-5L and SF-6D-V2 in Patients With Colorectal and Breast Cancer From a Developing Country
    Yousefi, Mahmood
    Nahvijou, Azin
    Sari, Ali Akbari
    Ameri, Hosein
    VALUE IN HEALTH REGIONAL ISSUES, 2021, 24 : 57 - 66
  • [40] Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D
    Versteegh, Matthijs M.
    Leunis, Annemieke
    Luime, Jolanda J.
    Boggild, Mike
    Uyl-de Groot, Carin A.
    Stolk, Elly A.
    MEDICAL DECISION MAKING, 2012, 32 (04) : 554 - 568